Crinetics Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
/ 
Frequently asked questions
To buy Crinetics Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Crinetics Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Crinetics Pharmaceuticals Inc. is CRNX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Crinetics Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Crinetics Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Crinetics Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Crinetics Pharmaceuticals Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Crinetics Pharmaceuticals Inc. or others.